Ceftazidime-avibactam in urinary tract infections due to carbapenemase-producing Klebsiella in kidney transplantation

Ceftazidime-avibactam in urinary tract infections due to carbapenemase-producing Klebsiella in kidney transplantation

Bibliographic Details
Main Authors:	Fernando Caravaca-Fontán, Sara Jiménez-Álvaro, Roberto Marcén-Letosa, Ana Fernández-Rodríguez, Carlos Quereda Rodríguez-Navarro
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	Nefrología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2013251415000784

Similar Items

Ceftazidima-avibactam en el tratamiento de infecciones urinarias por Klebsiella productora de carbapenemasa en trasplante renal
by: Fernando Caravaca-Fontán, et al.
Published: (2015-07-01)

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae
by: Wenxia Zhang, et al.
Published: (2018-11-01)

Emergence of ceftazidime- And avibactam-resistant klebsiella pneumoniae carbapenemase-producing Pseudomonas aeruginosa in China
by: Cai, H., et al.
Published: (2021)

MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates
by: Andrei Zidaru, et al.
Published: (2020-12-01)

Carbapenemase-producing Klebsiella pneumoniae intra-abdominal infection successfully treated with ceftazidime/avibactam plus tigecycline
by: Mariana Guedes, et al.
Published: (2020-01-01)

Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam
by: A. Schimmenti, et al.
Published: (2018-01-01)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
by: Yanqin Huang, et al.
Published: (2021-03-01)

Evaluation of In Vitro Activity of Ceftolozane-tazobactam and Ceftazidime-avibactam Against Carbapenemase-producing Multi-drug Resistant Klebsiella pneumoniae Isolates
by: Hüseyin Agah TERZİ, et al.
Published: (2020-12-01)

In vitro antibacterial activity of ceftazidime/avibactam in combination against planktonic and biofilm carbapenemase-producing Klebsiella pneumoniae isolated from blood
by: Chiara Papalini, et al.
Published: (2020-12-01)

In Vitro Activity of Ceftolozane/tazobactam and Ceftazidime/avibactam Against Carbapenemase-producing Pseudomonas aeruginosa
by: Özlem AYDEMİR, et al.
Published: (2019-12-01)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01)

In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase
by: Chunlei Wang, et al.
Published: (2021-09-01)

Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam
by: Majed F. Alghoribi, et al.
Published: (2021-05-01)

Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01)

Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients
by: Juan J. Castón, et al.
Published: (2017-06-01)

Cure of recurring Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae septic shock episodes due to complicated soft tissue infection using a ceftazidime and avibactam-based regimen: a case report
by: Giustino Parruti, et al.
Published: (2019-01-01)

Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience
by: Gabriele Bianco, et al.
Published: (2021-03-01)

The Potential Use of Ceftazidime-Avibactam Against Carbapenem Resistant Klebsiella pneumoniae Clinical Isolates Harboring Different Carbapenemase Types in a Thai University Hospital
by: Nasomsong W, et al.
Published: (2021-07-01)

Resistance to ceftazidime–avibactam and underlying mechanisms
by: Yuhang Wang, et al.
Published: (2020-09-01)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
by: Basem M. Alraddadi, et al.
Published: (2019-09-01)

Carbapenem-Resistant Klebsiella pneumoniae Osteomyelitis Treated with Ceftazidime-Avibactam in an Infant: A Case Report
by: Ji Z, et al.
Published: (2021-08-01)

Emergence of Hypervirulent Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Isolates in a Chinese Tertiary Hospital
by: Li D, et al.
Published: (2020-08-01)

Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis
by: Marco Fiore, et al.
Published: (2020-07-01)

In vitro activity of ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae in Greece: A single-centre study
by: Efthymia Protonotariou, et al.
Published: (2020-03-01)

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
by: Dan Li, et al.
Published: (2021-09-01)

OXA-48 carbapenemase-mediated ceftazidime-avibactam resistance; first reported case in Saudi Arabia's western region and review of literature
by: Y Al Dabbagh, et al.
Published: (2020-02-01)

Investigating the mechanism of ceftazidime-avibactam resistance in addition to the effect of vancomycin on antibacterial resistance in carbapenem-resistant Klebsiella pneumonia
by: Nour Sherri, et al.
Published: (2020-12-01)

Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China
by: Yixin Kang, et al.
Published: (2021-12-01)

Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
by: Melissa D. Barnes, et al.
Published: (2017-10-01)

Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Sequence Type 11 Due to a Mutation in Plasmid-Borne blakpc-2 to blakpc-33, in Henan, China
by: Li D, et al.
Published: (2021-05-01)

Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy?
by: Paola Bocanegra-Ibarias, et al.
Published: (2020-12-01)

Emerging carbapenemase Klebsiella oxytoca with multidrug resistance implicated in urinary tract infection
by: Falah Hasan Obayes AL-Khikani, et al.
Published: (2020-01-01)

First Study of Antimicrobial Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infection in Tehran, Iran
by: Rahimzadeh M, et al.
Published: (2020-02-01)

Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections
by: Hidalgo JA, et al.
Published: (2016-07-01)

Increased gene expression and copy number of mutated bla KPC lead to high-level ceftazidime/avibactam resistance in Klebsiella pneumoniae
by: Lingxiao Sun, et al.
Published: (2021-08-01)

Molecular and phenotypical characterization of two cases of antibiotic-driven ceftazidime-avibactam resistance in blaKPC-3-harboring Klebsiella pneumoniae
by: Venditti C, et al.
Published: (2019-07-01)

In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)

Interactions between Avibactam and Ceftazidime-Hydrolyzing Class D β-Lactamases
by: Jean-Marie Frère, et al.
Published: (2020-03-01)

Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms
by: Adnan Alatoom
Published: (2017-09-01)

Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
by: Goodlet KJ, et al.
Published: (2016-12-01)